Notice of Annual General Meeting of NeuroVive Pharmaceutical AB (publ) The shareholders of NeuroVive Pharmaceutical AB (publ), corporate identity number 556595-6538, are hereby convened to the Annual General Meeting, held at 4 p.m. on Thursday, 25 April 2019 at Medicon Village, Scheelevägen 2, in Lund, Sweden, with admission for registration from 3.30 p.m. Entitlement to participate and notification Shareholders that wish to participate at the Annual General Meeting should obe included in the share register maintained by Euroclear Sweden AB on Wednesday 17 April 2019, and onotify the Company by email toanmalan@neurovive.comor, in writing to NeuroVive Pharmaceutical AB, Medicon Village,...
|
